Fresenius Valuation
| FSNUY Stock | USD 8.54 0.17 1.95% |
At this time, the firm appears to be overvalued. Fresenius SE shows a prevailing Real Value of $7.66 per share. The current price of the firm is $8.54. Our model computes the value of Fresenius SE from reviewing the firm fundamentals such as Current Valuation of 43.74 B, profit margin of 0.04 %, and Shares Outstanding of 2.25 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Fresenius' price fluctuation is not too volatile at this time. Calculation of the real value of Fresenius SE is based on 3 months time horizon. Increasing Fresenius' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Fresenius is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresenius Pink Sheet. However, Fresenius' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.54 | Real 7.66 | Hype 8.54 | Naive 8.25 |
The intrinsic value of Fresenius' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresenius' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresenius SE Co helps investors to forecast how Fresenius pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresenius more accurately as focusing exclusively on Fresenius' fundamentals will not take into account other important factors: Fresenius Total Value Analysis
Fresenius SE Co is currently anticipated to have takeover price of 43.74 B with market capitalization of 17.65 B, debt of 27.16 B, and cash on hands of 2.13 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Fresenius fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
43.74 B | 17.65 B | 27.16 B | 2.13 B |
Fresenius Investor Information
The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius SE has Price/Earnings To Growth (PEG) ratio of 1.01. The entity last dividend was issued on the 16th of May 2022. The firm had 3:2 split on the 5th of August 2014. Based on the key indicators related to Fresenius' liquidity, profitability, solvency, and operating efficiency, Fresenius SE Co is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Fresenius Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fresenius has an asset utilization ratio of 52.14 percent. This suggests that the Company is making $0.52 for each dollar of assets. An increasing asset utilization means that Fresenius SE Co is more efficient with each dollar of assets it utilizes for everyday operations.Fresenius Profitability Analysis
The company reported the revenue of 37.52 B. Net Income was 1.82 B with profit before overhead, payroll, taxes, and interest of 10.26 B.About Fresenius Valuation
Our relative valuation model uses a comparative analysis of Fresenius. We calculate exposure to Fresenius's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fresenius's related companies.KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people.
8 Steps to conduct Fresenius' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fresenius' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fresenius' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Fresenius' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Fresenius' revenue streams: Identify Fresenius' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Fresenius' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Fresenius' growth potential: Evaluate Fresenius' management, business model, and growth potential.
- Determine Fresenius' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fresenius' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Fresenius Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.2 B | |
| Quarterly Earnings Growth Y O Y | -0.229 | |
| Forward Price Earnings | 7.8003 | |
| Retained Earnings | 14.9 B |
Additional Tools for Fresenius Pink Sheet Analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.